By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.) 

9620 Medical Center Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-864-2600 Fax: 301-315-2437


Company News
CASI Pharmaceuticals  (CASI) To Raise $25.1 Million In Private Placement Of Common Stock And Warrants 9/21/2015 11:40:31 AM
CASI Pharmaceuticals  (CASI) Reports Second Quarter 2015 Financial Results 8/14/2015 7:22:46 AM
CASI Pharmaceuticals  (CASI) Appoints Leading Oncology Experts To Newly Formed Clinical Advisory Board 7/27/2015 10:10:56 AM
CASI Pharmaceuticals  (CASI) Announces Availabilty Of Anti-Cancer Drug ZEVALIN In Hong Kong For Non-Hodgkin's Lymphoma 7/20/2015 8:53:58 AM
BIO2015: CASI Pharmaceuticals  (CASI) To Present At The 2015 BIO International Convention 6/11/2015 7:52:09 AM
CASI Pharmaceuticals  (CASI) Files New Drug Clinical Trial Application With China FDATo Expand U.S. Development Of ENMD-2076 In Fibrolamellar Carcinoma 6/4/2015 6:31:21 AM
CASI Pharmaceuticals  (CASI) Reports First Quarter 2015 Financial Results 5/15/2015 7:22:45 AM
CASI Pharmaceuticals  (CASI) Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3/30/2015 6:01:52 AM
CASI Pharmaceuticals  (CASI) Reports 2014 Fourth Quarter And Full Year Financial Results 3/27/2015 7:31:17 AM
CASI Pharmaceuticals  (CASI) Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 3/25/2015 6:19:46 AM